Why Birmingham and West Midlands

The West Midlands is making a difference on a global scale, with a 4.7m diverse population of potential trial participants, 8 NHS trusts, 80 local hospitals and clinics, 35 regional centres of clinical research excellence, and recognition as the top leading UK location for clinical trials, the region is an advantageous place to develop pharmaceuticals, medical devices, and advance data-driven decision making in healthcare. 

The West Midlands has one of the most dynamic Healthcare, MedTech and Data-Driven economies in the UK, home to over 17,000 healthcare professionals, 9,000+ MedTech specialists, 4,000 bio-pharma workers and 3,000 medical devices experts. These outstanding life sciences strengths make the region investment-ready for start-ups, scale-ups and established businesses across multiple healthcare sectors and clinical settings. 

The West Midlands Growth Company and DBT are delighted to welcome this delegation to Birmingham, where the region’s strengths in life sciences and data driven healthcare innovation will be showcased.

Delegates will be invited to hear more about opportunities available in the region, which will include an overview of how the West Midlands Growth Company can support businesses entering into the UK market with a bespoke soft-landing support package.

There will also be many opportunities to meet with key organisations within the dynamic and innovation life sciences ecosystem such as local universities, and organisations such as Medilink Midlands and Health Innovation West Midlands who both support the growth and innovation of the life sciences and healthcare ecosystem.

Precision Medicine and Medtech in Wales 

Wales stands out in the UK for its strengths in precision medicine and medtech. Wales has over 13,000 skilled professionals across 300 life science companies and a robust industry turnover of £2.8bn, with recognised strengths in medtech, diagnostics, neurosciences, genomics, and cell therapy. Cardiff is a recognised Centre of Excellence for Precision Medicine within the UK with a strong track record of partnering with business.

Wales is committed to building and expanding on its foundation of excellence in clinical research and industry partnership offering a wide range of exciting opportunities for companies to invest and grow their business in Wales. We offer access to a collaborative and supportive life sciences ecosystem with established clusters of excellence in high-growth markets including, in vitro diagnostic, single use technology, wound care and precision medicine.

With this in mind, the UK’s Department for Business and Trade (DBT) and Welsh Government are pleased to welcome Nordic and Baltic companies to Wales to showcase the business and innovation opportunities that lie within the Precision Medicine and medtech sector.

What will the visit to Wales include:

The visit can be tailored to the companies that join the delegation to include visits or introductions to key industry centres of excellence and innovation hubs such as the Wales Genomic Health Centre, Cardiff Edge Science Park, Cardiff Medi Centre, PDR (providing internationally acclaimed medical device design expertise), the Tritech Institute (real world evaluation of health technology), the Assistive Technologies Innovation Centre (ATIC), Institute of Life Sciences, or Centre for Nanohealth.

Delegates will also meet with key organisations supporting companies to grow and identify business opportunities in Wales including Medi Wales, the Life Sciences Hub Wales and Welsh Government where they will learn about navigating the ecosystem in Wales. The programme will also seek to include B2B opportunities.
 

• Privacy and cookies
• Terms and conditions
• Performance
• Department for Business and Trade on GOV.UK